European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 23, Status: Authorised

Submitted by Anonymous (not verified) on 25 April 2024 - 16:12

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 23, Status: Authorised

Committee for Medicinal Products for Veterinary Use (CVMP): 16-18 April 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2024 to 18 April 2024

Submitted by Anonymous (not verified) on 25 April 2024 - 16:09

Committee for Medicinal Products for Veterinary Use (CVMP): 16-18 April 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2024 to 18 April 2024

Veterinary medicines European public assessment report (EPAR): Innovax-ND-H5, Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5, St

Submitted by Anonymous (not verified) on 25 April 2024 - 15:36

Veterinary medicines European public assessment report (EPAR): Innovax-ND-H5, Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5, Status: Opinion

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 April 2024, 10:00 (CEST) to 10 April 2024, 12:30 (CEST)

Submitted by Anonymous (not verified) on 25 April 2024 - 14:39

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 April 2024, 10:00 (CEST) to 10 April 2024, 12:30 (CEST)

EMA workshop on the challenges in drug development, regulation and clinical practice in hemoglobinopathies, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 14:00 (CEST) to 1 July 2024, 18:00 (CEST)

Submitted by Anonymous (not verified) on 25 April 2024 - 14:28

EMA workshop on the challenges in drug development, regulation and clinical practice in hemoglobinopathies, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 14:00 (CEST) to 1 July 2024, 18:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness